Stockreport

Investors in Bio-Rad Laboratories (NYSE:BIO) have unfortunately lost 47% over the last five years [Yahoo! Finance]

Bio-Rad Laboratories, Inc. Class B  (BIO.B) 
PDF NYSE:BIO ) share price up 12% in a single quarter. But over the last half decade, the stock has not performed well. You would have done a lot better buying an index fund [Read more]